Rating History for Opiant Pharma (OPNT) by Northland

More Stocks Rated by Northland | Latest Ratings for OPNT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/23/2022 Carl Byrnes Downgrade Market Perform
(Outperform)		 22.00
(N/A)		 20.09
(20.65)		 2.79% Details